Volitionrx Ltd. (VNRX) intrinsic value & 10-year financials
Volitionrx Ltd. (VNRX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 115.8% a year to $1.7M, with an average return on invested capital of 6599.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.18
- Market cap
- $19.2M
- Revenue (FY2025)
- $1.7M
- Revenue growth (10-yr CAGR)
- 115.8%
- ROIC (10-yr avg)
- 6599.2%
- Free cash flow (FY2025)
- -$19.8M
VNRX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.7M | -$23.4M | — | -$19.8M | -1258.5% | 92.2% |
| FY2024 | $1.2M | -$27.3M | -$0.31 | -$26.2M | -2190.9% | 119.7% |
| FY2023 | $775.3K | -$35.7M | -$0.50 | -$19.1M | -4641.8% | 221.4% |
| FY2022 | $306.4K | -$30.6M | — | -$16.8M | -10372.4% | 726.8% |
| FY2021 | $90.0K | $137.0M | — | -$21.8M | -31469.0% | 14104.5% |
| FY2020 | $13.4K | $110.2M | — | -$18.4M | -158176.2% | 11812.6% |
| FY2019 | $17.1K | -$89.8M | — | -$13.3M | -93840.2% | -6780.2% |
| FY2018 | — | -$18.0M | — | -$15.0M | — | -1205.2% |
| FY2017 | — | -$55.7M | — | -$13.6M | — | -10288.2% |
| FY2016 | — | -$40.9M | — | -$9.5M | — | 57188.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
VOLITIONRX LTD revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
VOLITIONRX LTD has earned high returns on invested capital, averaging 87.0% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, VOLITIONRX LTD shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, VOLITIONRX LTD is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-7.26 per share.